Terns Net Income From Continuing Ops from 2010 to 2026
| TERN Stock | USD 34.60 0.40 1.17% |
Net Loss | First Reported 2019-12-31 | Previous Quarter -24.1 M | Current Value -24.6 M | Quarterly Volatility 5.9 M |
Check Terns Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Terns Pharmaceuticals' main balance sheet or income statement drivers, such as Tax Provision of 328.6 K, Net Interest Income of 16 M or Interest Income of 16 M, as well as many indicators such as Price To Sales Ratio of 143, Dividend Yield of 0.0 or PTB Ratio of 1.39. Terns financial statements analysis is a perfect complement when working with Terns Pharmaceuticals Valuation or Volatility modules.
Terns | Net Income From Continuing Ops | Build AI portfolio with Terns Stock |
Evaluating Terns Pharmaceuticals's Net Income From Continuing Ops across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Terns Pharmaceuticals's fundamental strength.
Latest Terns Pharmaceuticals' Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Terns Pharmaceuticals over the last few years. It is Terns Pharmaceuticals' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Terns Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Terns Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (42,650,105) | |
| Coefficient Of Variation | (69.39) | |
| Mean Deviation | 26,325,653 | |
| Median | (18,018,000) | |
| Standard Deviation | 29,596,813 | |
| Sample Variance | 876T | |
| Range | 72.2M | |
| R-Value | (0.88) | |
| Mean Square Error | 207.7T | |
| R-Squared | 0.78 | |
| Slope | (5,168,720) | |
| Total Sum of Squares | 14015.5T |
Terns Net Income From Continuing Ops History
About Terns Pharmaceuticals Financial Statements
Terns Pharmaceuticals investors utilize fundamental indicators, such as Net Income From Continuing Ops, to predict how Terns Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -80 M | -84 M |
Pair Trading with Terns Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Terns Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Terns Stock
| 0.8 | MRK | Merck Company Earnings Call This Week | PairCorr |
| 0.74 | GOOG | Alphabet Class C Earnings Call This Week | PairCorr |
Moving against Terns Stock
| 0.74 | MSFT | Microsoft | PairCorr |
| 0.68 | PG | Procter Gamble | PairCorr |
| 0.63 | NVDA | NVIDIA Aggressive Push | PairCorr |
| 0.48 | T | ATT Inc Earnings Call This Week | PairCorr |
| 0.43 | HD | Home Depot | PairCorr |
The ability to find closely correlated positions to Terns Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Terns Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Terns Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Terns Pharmaceuticals to buy it.
The correlation of Terns Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Terns Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Terns Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Terns Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Terns Pharmaceuticals Correlation against competitors. To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Will Pharmaceuticals sector continue expanding? Could Terns diversify its offerings? Factors like these will boost the valuation of Terns Pharmaceuticals. If investors know Terns will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Terns Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Terns Pharmaceuticals requires distinguishing between market price and book value, where the latter reflects Terns's accounting equity. The concept of intrinsic value—what Terns Pharmaceuticals' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Terns Pharmaceuticals' price substantially above or below its fundamental value.
Please note, there is a significant difference between Terns Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Terns Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Terns Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.